Brind.

Nicholas Waters appointed EVP and Head of R&D at Sto

1 report, 1 independent Updated Fri 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Nicholas Waters has been appointed as the Executive Vice President and Head of Research and Development at Sto. Sto is a German company that has pharmaceutical products regulated by the FDA.

Why it matters

Some supportBrind's analysis of the reports

The appointment of a new leader in Research and Development at Sto could influence the company's pipeline of treatments and its long-term research strategy.

Who's involved

  • Nicholas WatersNew Executive Vice President and Head of Research and Development at Sto
  • StoGerman pharmaceutical company whose products are regulated by the FDA

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped